Safety & Candidacy Multi-peptide therapy requires thorough medical evaluation to ensure safe and appropriate use
Single-cell RNAseq reveals seven classes of colonic sensory neuron
The addition of data from AMPLITUDE-O trial to the seven-trial meta-analysis [5] showed that patients with type 2 diabetes who received GLP-1 agonists had a decreased risk of MACE and decreased individual components (stroke more than myocardial infarction), independently of the structure of these drugs (exendine-4 based or human analogs)
When glutathione levels are strong, your body clears waste more efficiently, which leaves you feeling lighter, more focused, and more balanced
First, we studied 2 million patients diagnosed with type 2 diabetes who had a healthcare encounter between January 1, 2017, and October 31, 2024